Scott Platshon

Scott Platshon serves as the Chief Business Officer of Zymeworks, Inc., where he is responsible for driving the company's business development strategies. He recently highlighted the potential financial gains from the acquisition of Theravance Biopharma, particularly in relation to royalties from the respiratory drug Yupelri and other future sales milestones.